These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 8104017

  • 1. Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance.
    Brookhuis KA, De Vries G, De Waard D.
    Br J Clin Pharmacol; 1993 Jul; 36(1):67-70. PubMed ID: 8104017
    [Abstract] [Full Text] [Related]

  • 2. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers.
    Hindmarch, Shamsi Z.
    Curr Med Res Opin; 2001 Jul; 17(4):273-81. PubMed ID: 11922401
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of two antihistamine drugs on actual driving performance.
    Betts T, Markman D, Debenham S, Mortiboy D, McKevitt T.
    Br Med J (Clin Res Ed); 1984 Jan 28; 288(6413):281-2. PubMed ID: 6140978
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Placebo controlled comparison of acute effects of ebastine and clemastine on performance and EEG.
    Hopes H, Meuret GH, Ungethüm W, Leopold G, Wiemann H.
    Eur J Clin Pharmacol; 1992 Jan 28; 42(1):55-9. PubMed ID: 1347267
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dose-response relationship of the H1-histamine antagonist, ebastine, against histamine and methacholine-induced bronchoconstriction in patients with asthma.
    Wood-Baker R, Holgate ST.
    Agents Actions; 1990 Apr 28; 30(1-2):284-6. PubMed ID: 1973585
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The psychomotor and cognitive effects of a new antihistamine, mizolastine, compared to terfenadine, triprolidine and placebo in healthy volunteers.
    Kerr JS, Dunmore C, Hindmarch I.
    Eur J Clin Pharmacol; 1994 Apr 28; 47(4):331-5. PubMed ID: 7875184
    [Abstract] [Full Text] [Related]

  • 16. Effects of two antihistamine drugs on actual driving performance.
    Cohen AF, Posner J.
    Br Med J (Clin Res Ed); 1984 Mar 24; 288(6421):935. PubMed ID: 6142749
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacodynamic and pharmacokinetics of BW 825C: a new antihistamine.
    Cohen AF, Hamilton MJ, Liao SH, Findlay JW, Peck AW.
    Eur J Clin Pharmacol; 1985 Mar 24; 28(2):197-204. PubMed ID: 2859204
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects.
    Vincent J, Liminana R, Meredith PA, Reid JL.
    Br J Clin Pharmacol; 1988 Nov 24; 26(5):497-502. PubMed ID: 2905150
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.